Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 12, 2005, Pages 1392-1399

  Brianzoni, Ernesto ^a   Rossi, Gloria ^a   Ancidei, Sergio ^a   Berbellini, Alfonso ^a   Capoccetti, Francesca ^a   Cidda, Carla ^a   D'Avenia, Paola ^a   Fattori, Sara ^a   Montini, Gian Carlo ^a   Valentini, Gianluca ^a   Proietti, Alfredo ^a  

^a S Lucia Hospital   (Italy)

Author keywords

Clinical target volume; Gross tumour volume; Head and neck cancer; Lung cancer; PET CT co registration; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VOLUME; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 28544447029     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1845-5     Document Type: Article

References (29)

1. Bujenovic S. The role of positron emission tomography in radiation treatment planning. Semin Nucl Med 2004;34:293-9
2. Wahl RL, Quint LE, Greenough RL,Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images preliminary prospective evaluation. Radiology 1994;191:371-7
3. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME. A tabulated summary of the FDG-PET literature. J Nucl Med 2001;42:1S-93S
4. Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 2004;45:543-52
5. Perez CA, Bradley J, Chao CKS, Grigsby PW, Mutic S, Malyapa R. Functional imaging in treatment planning in radiation therapy: a review. Rays 2002;27:157-73
6. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157-64
7. Daisne JF, Sibomana M, Bol A, Cosnard G, Lonneux M, Gregoire V. Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. Radiother Oncol 2003;69:237-45
8. 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000;55:317-24
9. Chapman JD, Bradley JD, Eary JF, Haubner R, Larson SM, Michalski JM, et al. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys 2003;55:294-301
10. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-7
11. Miller T, Grigsby P. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated with radiation therapy. Int. J Radiat Oncol Biol Phys 2002;53:353-9
12. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999;44:593-7
13. Giraud P, Elles S, Helfre S, De Rycke Y, Servois V, Carette MF, et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 2002;62:27-36
14. Armstrong JG. Target volume definition for three-dimensional conformal radiation therapy of lung cancer. Br J Radiol 1998;71:587-94
15. Rosenman J. Incorporating functional imaging information into radiation treatments. Semin Radiat Oncol 2001;11:83-92
16. Hebert ME, Lowe VJ, Hoffman JM, Patz EF, Anscher MS. Positron emission tomography in the pretreatment evaluation and follow-up of non Small Cell Lung Cancer patients treated with radiotherapy: preliminary findings. Am J Clin Oncol 1996;19:416-21
17. Hu Y, Erdi A, Chui C. A 3D image registration toolkit for radiation therapy treatment planning. Med Phys 1999;26:1160
18. 18F-fluorodeoxyglucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998;19:167-77
19. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003;123:137S-46S
20. Erdi YE, Rosenzweig K, Erdi AK, Macapinlac HA, Hu YC, Braban LE, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002;62:51-60
21. Bradley JD, Perez CA, Dehdashti F, Siegel BA. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med 2004;45 (Suppl 1):96-101
22. Munley MT, Marks LB, Scarfone C, Sibley GS, Patz EF Jr, Turkington TG, et al. Multimodality nuclear medicine imaging in radiation treatment planning for lung cancer: challenges and prospects.Lung Cancer 1999;23:105-14
23. MacManus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001;92:886-95
24. 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 2001;49:1249-57
25. 18FDG-PET on target and critical organs in CT-based treatment planning or patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002;52:339-50
26. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60
27. Paulino AC, Johnstone PA. FDG-PET in radiotherapy treatment planning: pandora's box?. Int J Radiat Oncol Biol Phys 2004;59:4-5
28. Bradley JD, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2004;59:78-85
29. Van de Wiele C, Lahorte C, Oyen W, Boerman O, Goethals I, Slegers G, et al. Nuclear Medicine Imaging to predict response to radiotherapy: a review. Int J Radiat Oncol Biol Phys 2003;55:5-15